A randomized trial of ciprofloxacin plus azlocillin versus netilmicin plus azlocillin for the empirical treatment of fever in neutropenic patients.
Hyatt
D S
DS
Rogers
T R
TR
McCarthy
D M
DM
Samson
D S
DS
D001390:Azlocillin / Q000009:adverse effects / Q000627:therapeutic use*; D002939:Ciprofloxacin / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005334:Fever / Q000188:drug therapy*; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy; D006801:Humans; D009428:Netilmicin / Q000009:adverse effects / Q000627:therapeutic use*; D009503:Neutropenia / Q000150:complications; D011446:Prospective Studies
D009428:Netilmicin; D002939:Ciprofloxacin; D001390:Azlocillin